Literature DB >> 6303116

A prospective investigation of bovine leukemia virus infection in young dairy cattle, using survival methods.

M C Thurmond, K M Portier, D M Puhr, M J Burridge.   

Abstract

The authors studied bovine leukemia virus infection in cattle born between July 1, 1979, and June 30, 1981, and followed up to 27 months in the University of Florida Dairy Research Unit herd, a 200-cow milking herd. Cattle were tested monthly for antibodies to the virus by agar-gel immunodiffusion with the glycoprotein-51 antigen. Of 473 live calves entering the study at birth, 54 became infected during the course of the study. Rates of detection of bovine leukemia virus infection were examined using survival methods. Plotted cumulative hazard rates revealed a nonlogarithmic survivorship function and three age-specific detection phases. These phases were 0-6 months, 7-16 months, and 17-26 months of age with estimated incidence rates of 5.25, 2.14, and 14.37 new detections per 10,000 cattle-days at risk, respectively. Significant differences were found between incidence rates of the first and second phase (p = 0.0168) and between those of the second and third phase (p less than 0.0001); corresponding relative risks were 0.41 and 6.71, respectively. The reduced incidence rate of the second phase coincided with movement of calves from a crowded calf barn to pastures. The increased incidence rate of the third phase coincided with mixing of bred heifers with bovine leukemia virus-infected dry cows. Increased incidence rates did not coincide with common-needle vaccination or artificial insemination. Evidence was not found for milk-borne infection. Age-specific detection rates were not associated with dam parity (p = 0.93), dam age (p = 0.79), breed (p = 0.60), or consumption of colostrum from cows infected with the virus (p = 0.23). However, detection rates were lower in cattle born to bovine leukemia virus-infected cows than in those born to noninfected cows (p = 0.03).

Entities:  

Mesh:

Year:  1983        PMID: 6303116     DOI: 10.1093/oxfordjournals.aje.a113585

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

1.  Production and related variables in bovine leukaemia virus-infected cows.

Authors:  R M Jacobs; J L Heeney; M A Godkin; K E Leslie; J A Taylor; C Davies; V E Valli
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

2.  Serological study of the incidence and prevalence of antibodies to bovine leukemia virus in aged sera.

Authors:  M E Hugh-Jones; P Moorhouse; C L Seger
Journal:  Can J Comp Med       Date:  1984-10

3.  Effect of brucellosis vaccination and dehorning on transmission of bovine leukemia virus in heifers on a California dairy.

Authors:  M L Lassauzet; M C Thurmond; W O Johnson; F Stevens; J P Picanso
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

4.  Protection of colostral antibodies against bovine leukemia virus infection in calves on a California dairy.

Authors:  M L Lassauzet; W O Johnson; M C Thurmond; F Stevens
Journal:  Can J Vet Res       Date:  1989-10       Impact factor: 1.310

5.  Using scenario tree modelling for targeted herd sampling to substantiate freedom from disease.

Authors:  Sarah Blickenstorfer; Heinzpeter Schwermer; Monika Engels; Martin Reist; Marcus G Doherr; Daniela C Hadorn
Journal:  BMC Vet Res       Date:  2011-08-16       Impact factor: 2.741

6.  Using shared needles for subcutaneous inoculation can transmit bluetongue virus mechanically between ruminant hosts.

Authors:  Karin E Darpel; James Barber; Andrew Hope; Anthony J Wilson; Simon Gubbins; Mark Henstock; Lorraine Frost; Carrie Batten; Eva Veronesi; Katy Moffat; Simon Carpenter; Chris Oura; Philip S Mellor; Peter P C Mertens
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

Review 7.  Biosecurity and risk management for dairy replacements.

Authors:  Fiona Maunsell; G Arthur Donovan
Journal:  Vet Clin North Am Food Anim Pract       Date:  2008-03       Impact factor: 3.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.